During the past decade, Medstar Georgetown University Hospital - Department of Dermatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medstar Georgetown University Hospital - Department of Dermatology" are "Alopecia Areata" (2 trials). Many other conditions were trialed in "Medstar Georgetown University Hospital - Department of Dermatology" in a lesser frequency.

Most popular intervention types in "Medstar Georgetown University Hospital - Department of Dermatology" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine" (1 trials), "PF-06651600" (1 trials), "PF-06651600 Induction Dose" (1 trials), "PF-06651600 Maintenance Dose #1" (1 trials) and "PF-06651600 Maintenance Dose #2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medstar Georgetown University Hospital - Department of Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medstar Georgetown University Hospital - Department of Dermatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Medstar Georgetown University Hospital - Department of Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medstar Georgetown University Hospital - Department of Dermatology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".